The USFDA approval for Aurobindo Pharma's first metered-dose inhaler takes its cumulative ANDA approvals to 596, strengthening its complex product portfolio.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.